Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)

Historical Holders from Q3 2024 to Q3 2025

Symbol
BCAX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
54.3M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
50M
Holdings value
$789M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
112
Number of buys
63
Number of sells
-43
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Invus Global Management, LLC 9.6% $50.7M 5.22M Raymond Debbane 30 Jun 2025
Vestal Point Capital, LP 9.2% +82% $48.6M $21.7M 5M +80.6% Vestal Point Capital, LP 30 Jun 2025
FMR LLC 5.1% +8% $25.6M $2.02M 2.76M +8.58% FMR LLC 10 Jul 2025

Institutional Holders of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 50M $789M +$2.78M $15.79 112
2025 Q2 51.2M $475M -$6.69M $9.29 105
2025 Q1 48.6M $633M +$9.52M $13.03 92
2024 Q4 46.7M $814M +$73.9M $17.42 84
2024 Q3 36.4M $927M +$849M $25.47 69